Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies?

C. Hewison (Paris, France)

Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Disease area: Respiratory infections

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Hewison (Paris, France). Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies?. International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: